Systemic neoadjuvant therapy of luminal breast cancer in 2016

被引：2
|
作者：
Cottu, Paul H. [1 ]
机构：
[1] PSL Res Univ, Inst Curie, Dept Med Oncol, 26 Rue Ulm, F-75005 Paris, France
来源：
BULLETIN DU CANCER | 2017年 / 104卷 / 01期
关键词：
Luminal breast cancer; Neoadjuvant; Endocrine therapy; Chemotherapy; PATHOLOGICAL COMPLETE RESPONSE; ADJUVANT ENDOCRINE THERAPY; RANDOMIZED PHASE-II; POSTMENOPAUSAL PATIENTS; EVALUATING ANASTROZOLE; TRIAL; CHEMOTHERAPY; WOMEN; COMBINATION; LETROZOLE;
D O I：
10.1016/j.bulcan.2016.09.021
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Neoadjuvant systemic therapies have been extensively evaluated in luminal breast cancer. Conventional cytotoxic chemotherapy increases breast conservation rate, albeit with a low level of complete pathological response of uncertain clinical significance. Endocrine therapies allow similar clinical results with much less side effects. Biological criteria of response to endocrine therapies are still being defined. The neoadjuvant setting must be used for early development of new compounds and to further document biological mechanisms of sensitivity and resistance to treatments.
引用
收藏
页码：69 / 78
页数：10
相关论文
共 50 条
  • [31] Discussion of: Neoadjuvant systemic therapy in invasive lobular breast cancer: Is it indicated?
    Sener, Stephen
    Tsung, Karen
    [J]. AMERICAN JOURNAL OF SURGERY, 2018, 215 (03): : 513 - 514
  • [32] Neoadjuvant Systemic Treatment of Breast Cancer
    Makhoul, Issam
    Kiwan, Elias
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2011, 103 (04) : 348 - 357
  • [33] Neoadjuvant Therapy for Breast Cancer
    Murphy, Conleth
    [J]. ONCOLOGY-NEW YORK, 2009, 23 (11): : 20 - 27
  • [34] Neoadjuvant Therapy for Breast Cancer
    Liu, Stephen V.
    Melstrom, Laleh
    Yao, Kathy
    Russell, Christy A.
    Sener, Stephen F.
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2010, 101 (04) : 283 - 291
  • [35] Neoadjuvant therapy for breast cancer
    Mangone, Lucia
    Mancuso, Pamela
    Tagliabue, Giovanna
    Filiberti, Rosa Angela
    Carrozzi, Giuliano
    Iacovacci, Silvia
    Mazzucco, Walter
    Tumino, Rosario
    Minicozzi, Pamela
    Sant, Milena
    Rossi, Paolo Giorgi
    [J]. TUMORI JOURNAL, 2019, 105 (06): : 488 - 493
  • [36] Neoadjuvant Therapy in Breast Cancer
    Bruges, Ricardo
    Hernan Guzman, Luis
    Sanchez, Oswaldo
    Diaz, Sandra
    Vergara, Edgar
    [J]. REVISTA COLOMBIANA DE CANCEROLOGIA, 2009, 13 (03): : 157 - 174
  • [37] Neoadjuvant Therapy for Breast Cancer
    Zardavas, Dimitrios
    Piccart, Martine
    [J]. ANNUAL REVIEW OF MEDICINE, VOL 66, 2015, 66 : 31 - 48
  • [38] Histological Features of Neoadjuvant Endocrine Therapy Response and Effect on Tumour Phenotype in Luminal Breast Cancer
    Shaaban, A. M.
    Badr, N.
    [J]. JOURNAL OF PATHOLOGY, 2018, 246 : S11 - S11
  • [39] Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer
    Cottu, P.
    D'Hondt, V.
    Dureau, S.
    Lerebours, F.
    Desmoulins, I.
    Heudel, P-E
    Duhoux, F. P.
    Levy, C.
    Mouret-Reynier, M-A
    Dalenc, F.
    Frenel, J-S
    Jouannaud, C.
    Venat-Bouvet, L.
    Nguyen, S.
    Ferrero, J-M
    Canon, J-L
    Grenier, J.
    Callens, C.
    Gentien, D.
    Lemonnier, J.
    Vincent-Salomon, A.
    Delaloge, S.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 (12) : 2334 - 2340
  • [40] Breast surgery after neoadjuvant systemic therapy
    Pawloski, Kate R.
    Barrio, Andrea, V
    [J]. TRANSLATIONAL BREAST CANCER RESEARCH, 2024, 5
12345